Smoking Cessation Outcomes and Effective Factors

October 5, 2023 updated by: Saglik Bilimleri Universitesi

Smoking Cessation Outcomes and Effective Factors: Maximal Voluntary Breath-holding Time and Exercise Capacity

The study is a cross-sectional-descriptive study. Cases who met the inclusion criteria, agreed to participate in the study voluntarily, were active smokers, passive smokers and non-smokers will be included. The subjects will be given the maximal voluntary breath-hold test, the 6-minute walk test, and the 30-second sit-and-stand test, and will be asked to answer questions about smoking. The physical conditions of the groups will be compared.

Study Overview

Detailed Description

The study is a cross-sectional-descriptive study. Cases who met the inclusion criteria, agreed to participate in the study voluntarily, were active smokers, passive smokers and non-smokers will be included. Active smoking, passive smoking status and non-smoker status of the cases will be determined within the framework of the definitions given below.

  • Active smoker: Having smoked at least 1 cigarette per day for at least 2 years.
  • Passive smoker: Being exposed to secondhand smoke for more than 15 minutes at home, school, office or anywhere in the past year, once a week.
  • Non-smoker: Not being an active or passive smoker.

The subjects will be given the maximal voluntary breath-hold test, the 6-minute walk test, and the 30-second sit-and-stand test, and will be asked to answer questions about smoking.The physical conditions of the groups will be compared.

Study Type

Observational

Enrollment (Actual)

893

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Üsküdar
      • İstanbul, Üsküdar, Turkey, 34668
        • Esra Pehlivan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

Active, pasive smoker and non-smoker volunters

Description

Inclusion Criteria for Active Smokers

  • Being between the ages of 18-75
  • Smoking at least 1 cigarette a day for at least 2 years

Inclusion Criteria for the Passive Smoker Group

  • Being between the ages of 18-75
  • Being exposed to cigarette smoke for more than 15 minutes at home, school, office or anywhere in the last year, once a week.

Inclusion Criteria for the Non-Smoker Group

  • Being between the ages of 18-75
  • Not being an active or passive smoker

Exclusion Criteria:

  • Having any disease that prevents him from doing exercise tests
  • Not signing the voluntary informed consent form

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Active smokers
Having smoked at least 1 cigarette per day for at least 2 years.
Being active smoker
Pasive smokers
Being exposed to secondhand smoke for more than 15 minutes at home, school, office or anywhere in the past year, once a week.
Being exposed to secondhand smoke
Non-smokers
Not being an active or passive smoker.
Not being an active or passive smoker.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Six-minute walking test
Time Frame: 1 day
The subject will be asked to walk for 6 minutes on a flat surface of 30 meters and the distance covered will be recorded. The test will be performed in accordance with the American Thoracic Society guidelines
1 day
Maximal voluntary breath-hold time
Time Frame: 1 day
The maximum voluntary breath-hold test is a quick and simple test that consists of measuring the apnea time after a deep inspiration. The clinical utility of this test has been proven in certain respiratory pathologies. In the test, the subject will be seated in a chair with back support, a deep inspiration will be asked, and the breath-holding time will be recorded in seconds. The test will be repeated three times with sufficient rest periods in between, and the longest time will be analyzed.
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thirty Seconds Sit and Stand test
Time Frame: 1 day
During the test, the individual performs the sit-stand-sit maneuver from a standard height chair within 30 seconds without using his arms as much as possible. The number of sitting and standing up during this period is recorded.
1 day
Fagerstrom Nicotine Addiction Test
Time Frame: 1 day
Dependence analysis will be performed on smokers according to the Fagerström nicotine addiction test and the scales for evaluating the psychological dependence of cigarettes. It is a six-question questionnaire created by revising the Fagerstrom tolerance questionnaire. In the scoring made according to the answers given to the questions, 0-2 points is called very mild addiction and 8-10 points is called very severe addiction
1 day
Evaluation scale of psychological dependence on cigarette
Time Frame: 1 day
It is a scale used in the evaluation of psychological dependence on cigarettes. The possible scores range from 25 to 75. As the scale score increases, the degree of psychological dependence increases; Scoring; 25-41 score: mildly addicted 42-58 score: moderate addiction
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: ESRA PEHLİVAN, Saglik Bilimleri Universitesi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 23, 2023

Primary Completion (Actual)

September 27, 2023

Study Completion (Actual)

September 27, 2023

Study Registration Dates

First Submitted

December 26, 2022

First Submitted That Met QC Criteria

January 15, 2023

First Posted (Actual)

January 25, 2023

Study Record Updates

Last Update Posted (Actual)

October 6, 2023

Last Update Submitted That Met QC Criteria

October 5, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on Active Smoking

Subscribe